This Fall returning to... Baltimore
October 12th and 13th
Early Stage East's Bio-Life-Tech Conference will feature over 30 innovative companies seeking institutional venture capital. These select companies will come from the biotechnology, nanotechnology, life science, and pharmaceutical industries and the related fields. Bio-Life-Tech attracts companies to present and exhibit their unique, break-away businesses to investors who specialize in the early-stage financing of companies in their specific industries.
Sponsorship opportunities are available, but selling out quickly. Save up to $6,000 by sponsoring both 2004 Venture Conferences!
Early Stage East's 2003 Bio-Life-Tech Conference
November 5 & 6, 2003 Baltimore, MD
Early Stage East's second annual Bio-Life-Tech Conference was a huge success, featuring over 30 early stage companies from the biotechnology, life science, pharmaceutical and nanotechnology industries and related technology fields. To view, a list of the companies that participated in this year's Conference, click here. Over 350 attendees joined us over the two-day conference.
Company Award Winners
Company Most Likely to Receive Funding:
Advanced Vision Therapies
Peoples' Choice Award:
Hamilton Thorne Biosciences, Inc.
From left to right are: Michael Kaleko, President & CSO, Advanced Vision Therapies; Tianci Luo, Vice President, Research, Advanced Vision Therapies; Shiela Connolley, Vice President, Development, Advanced Vision Therapies; Jeffrey P. Libson, Partner, Pepper Hamilton, LLP and Event Co-Chair; Charles Morton, Partner Venable LLP and Bio-Life-Tech Awards Presenter; Harry McCoy, President, Hamilton Thorne Biosciences, Inc.; and Meg Hamilton, CEO, Hamilton Thorne Biosciences, Inc.